Hereditary inclusion body myopathy and other rimmed vacuolar myopathies

Handbook of Clinical Neurology

Volumn 86, Issue , 2007, Pages 243-253

  Argov, Zohar ^a   Mitrani Rosenbaum, Stella ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56049109405     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)86012-X     Document Type: Review

References (70)

1. Arai A., Tanaka K., Ikeuchi T., et al. A novel mutation in the GNE gene and a linkage disequilibrium in Japanese pedigrees. Ann Neurol 52 (2002) 516-519
2. Argov Z., and Mitrani-Rosenbaum S. Hereditary inclusion body myopathy (h-IBM) with quadriceps sparing: epidemiology andgenetics. In: Askanas V., Serratrice G., and Engel W.K. (Eds). Inclusion-body Myositis and Myopathies (1998), Cambridge University Press, Cambridge 200-210
3. Argov Z., and Soffer D. Hereditary inclusion body myopathies. In: Karpati G. (Ed). Structural and Molecular Basis of Skeletal Muscle Disease (2002), ISN Neuropath Press, Basel 274-276
4. Argov Z., and Yarom R. "Rimmed vacuole myopathy" sparing the quadriceps: a unique disorder in Iranian Jews. J Neurol Sci 64 (1984) 33-43
5. Argov Z., Sadeh M., Eisenberg I., et al. Facial involvement in hereditary inclusion body myositis. Neurology 50 (1998) 1925-1926
6. Argov Z., Eisenberg I., Grabov-Nardini G., et al. Hereditary inclusion body myopathy: the Middle Eastern genetic cluster. Neurology 60 (2003) 1519-1523
7. Askanas V., and Engel W.K. New advances in inclusion-body myositis. Curr Opin Rheumatol 5 (1993) 732-741
8. Askanas V., and Engel W.K. Newest approches to diagnosis of sporadic inclusion-body myositis and hereditary inclusion-body myopathies, including molecular-pathologic similarities to Alzheimer disease. In: Askanas V., Serratrice G., and Engel W.K. (Eds). Inclusion-Body Myositis and Myopathies (1998), Cambridge University Press, Cambridge 3-78
9. Beltran-Valero de Bernabe D., Currier A., Steinbrecher A., et al. Mutations in the O-mannosyltranferase gene POMT1give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 71 (2002) 1033-1043
10. Broccolini A., Pescatori M., D'Amico A., et al. An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene. Neurology 59 (2002) 1808-1809
11. Broccolini A., Ricci E., Cassandrini D., et al. Novel GNE mutations in Italian families with autosomal recessive hereditary inclusion-body myopathy. Hum Mutat 23 (2004) 632
12. Broccolini A., Gliubizzi C., Pavoni E., et al. α-dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy. Neuromuscul Disord 15 (2005) 177-184
13. Brockington M., Blake D.J., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin a2 deficiency and abnormal glycosylation of α-dystroglycan. Am J Hum Genet 69 (2001) 1198-1209
14. Cole A.J., Kuzniecky R., Karpati G., et al. Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. Brain 111 (1988) 1025-1037
15. Darin N., Kyllerman M., Wahlstrom J., et al. Autosomal dominant myopathy with congenital joint contractures, ophthalmoplegia, and rimmed vacuoles. Ann Neurol 44 (1998) 242-248
16. Darvish D., Vahedifar P., and Huo Y. Four novel mutations associated with autosomal recessive inclusion body myopathy (MIM: 600737). Mol Genet Metab 77 (2002) 252-256
17. Del Bo R., Baron P., Prelle A., et al. Novel missense mutation and large deletion of GNE gene in autosomal-recessive inclusion-body myopathy. Muscle Nerve 28 (2003) 113-117
18. Edelman G.M., and Crossin K.L. Cell adhesion molecules: implications for a molecular histology. Ann Rev Biochem 60 (1991) 155-190
19. Effertz K., Hinderlich S., and Reutter W. Selective loss of either the epimerase or kinase activity of UDP-N-acetylglucosamine 2 epimerase/N-acetylmannosamine kinase due to site-directed mutagenesis based on sequence alignments. J Biol Chem 274 (1999) 28771-28778
20. Eisenberg I., Avidan N., Potikha T., et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylemannosamine kinase is mutated in recessive hereditary inclusion body myopathy. Nat Genet 29 (2001) 83-87
21. Eisenberg I., Grabov-Nardini G., Hochner H., et al. Mutations spectrum of the GNE gene in hereditary inclusion body myopathy sparing the quadriceps. Hum Mutat 21 (2003) 99
22. Fardeau M., and Tomé F. Inclusion body myopathies. In: Askanas V., Serratrice G., and Engel W.K. (Eds). Inclusion-Body Myositis and Myopathies (1998), Cambridge University Press, Cambridge 252-260
23. Figarella-Branger D., Pellissier J.F., Bianco N., et al. Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product. Acta Neuropathol (Berl) 79 (1990) 528-536
24. Griggs R.C., Askanas V., DiMauro S., et al. Inclusion body myositis and myopathies. Ann Neurol 38 (1995) 705-715
25. Hayashi Y.K., Ogawa M., Tagawa K., et al. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57 (2001) 115-121
26. Hentati F., Ben Hamida C., Belal S., et al. Familial autosomal-recessive inclusion-body myositis with asymptomatic leukoencephalopathy. In: Askanas V., Serratrice G., and Engel W.K. (Eds). Inclusion-Body Myositis and Myopathies (1998), Cambridge University Press, Cambridge 211-220
27. Hentati F., Amouri R., Driss A., et al. Allelic heterogeneity of autosomal recessive inclusion body myopathy in Tunisia (abstr). J Neurol Sci 199 Suppl. 1 (2002) S50
28. Hinderlich S., Stasche R., Zeitler R., et al. A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Purification and characterization of UDP-N-acetylglucosamine 2 epimerase/N-acetylmannosamine kinase. J Biol Chem 272 (1997) 24313-24318
29. Hinderlich S., Salama I., Eisenberg I., et al. The homozygous M712T mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase results in reduced enzyme activities but not in altered cellular sialylation in hereditary inclusion body myopathy. FEBS Lett 566 (2004) 105-109
30. Horstkorte R., Nöhring S., Wiechens N., et al. Tissue expression and amino acid sequence of murine UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. Eur J Biochem 260 (1999) 923-927
31. Horstkorte R., Nohring S., Danker K., et al. Protein kinase C phosphorylates and regulates UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase. FEBS Lett 470 (2000) 315-318
32. Huizing M., Rakocevic G., Sparks, et al. Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations. Mol Genet Metab 81 (2004) 196-202
33. Hynes R.O., and Lander A.D. Contact and adhesive specificities in the associations, migrations and targeting of cells and axons. Cell 68 (1992) 303-322
34. Kayashima T., Matsuo H., Satoh A., et al. Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase gene (GNE). J Hum Genet 47 (2002) 77-79
35. Kelm S., and Schauer R. Sialic acids in molecular and cellular interactions. Int Rev Cytol 175 (1997) 137-240
36. Keppler T., Hinderlich S., Langner J., et al. UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. Science 284 (1999) 1372-1376
37. Konigsberg I.R. The embryonic origin of muscle. In: Engel A.G., and Banker B.Q. (Eds). Myology. 1st edn. Vol. 1 (1986), McGraw-Hill Book Company, New York 39-71
38. Kornfeld S., Kornfeld R., Neufeld E., et al. The feedback control of sugar nucleotide biosynthesis in liver. Proc Natl Acad Sci USA 52 (1964) 371-379
39. Krause S., Schlotter-Weigel B., Walter M.C., et al. A novel homozygous missense mutation in the GNE gene in a patient with quadriceps-sparing hereditary inclusion body myopathy associated with muscle inflammation. Neuromuscl Dis 13 (2003) 830-834
40. Krause S., Hinderlich S., Amsili S., et al. Localization of UDP-GlcNAc 2-epimerase/ManAc kinase (GNE) in the Golgi complex and the nucleus of mammalian cells. Exp Cell Res 304 (2005) 365-379
41. Lucka L., Krause M., Danker K., et al. Primary structure and expression analysis of human UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase, the bifunctional enzyme in neuraminic acid biosynthesis. FEBS Lett 454 (1999) 341-344
42. Martinsson T., Oldfors A., Darin N., et al. Autosomal dominant myopathy: missense mutation (Glu-706-Lys) in the myosin heavy chain IIa gene. Proc Natl Acad Sci USA 97 (2000) 14614-14619
43. McKee D., Karpati G., Carpenter S., et al. Familial inclusion body myositis (IBM) mimics facioscapulohumeral dystrophy (FSHD) (abstr). Neurology 42 Suppl. 3 (1992) 302
44. Mirabella M., Alvarez R.B., Bilak M., et al. Difference in expression of phosphorylated tau epitopes between sporadic inclusion body myositis and hereditary inclusion body myopathies. J Neuropathol Exp Neurol 55 (1996) 774-786
45. Mitrani-Rosenbaum S., Argov Z., Blumenfeld A., et al. Hereditary inclusion body myopathy maps to chromosome 9p1-q1. Hum Mol Genet 5 (1996) 159-163
46. Neufeld M.Y., Sadeh M., Assa B., et al. Phenotypic heterogeneity in familial inclusion body myopathy. Muscle Nerve 18 (1995) 546-548
47. Netzer A. The Jewish communities in Iran. Iranian Jews (1988), Koresh House-World Center of Iranian Jews in Israel, Holon 3-20
48. Neville H.E., Baumbach L.L., Ringel S.P., et al. Familial inclusion body myositis: evidence for autosomal dominant inheritance. Neurology 42 (1992) 897-902
49. Nishino I., Noguchi S., Murayama K., et al. Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. Neurology 59 (2002) 1689-1693
50. Noguchi S., Keira Y., Murayama K., et al. Reduction of UDP-N acetylglucosamine 2-epimerase/N-acetylmannosamine kinase activity and sialylation in distal myopathy with rimmed vacuoles. J Biol Chem 279 (2004) 11402-11407
51. Nonaka I., Sunohara N., Ishiura I., et al. Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. J Neurol Sci 51 (1981) 141-153
52. Reutter W., Stäsche R., Stehling P., et al. The biology of sialic acids. Insights into their structure,metabolism and function in particular during viral infection. In: Gabius H.J., and Gabius G. (Eds). Glycosciences. Status and Perspectives (1997), Chapman and Hall, Weinheim 245-259
53. Sadeh M., and Argov Z. Hereditary inclusion body myopathy in Jews of Persian origin: Clinical and laboratory data. In: Askanas V., Serratrice G., and Engel W.K. (Eds). Inclusion-Body Myositis and Myopathies (1998), Cambridge University Press, Cambridge 191-199
54. Sadeh M., Gadoth M., Hadar H., et al. Vacuolar myopathy sparing the quadriceps. Brain 116 (1993) 217-232
55. Saito F., Tomimitsu H., Arai K., et al. A Japanese patient with distal myopathy with rimmed vacuoles: missense mutations in the epimerase domain of the UDP-N-acetylglucosamine 2-epimerase N-acetylmannosaminekinase (GNE) gene accompanied by hyposialylation of skeletal muscle glycoproteins. Neuromuscul Disord 14 (2004) 158-161
56. Salama I., Hinderlich S., Shlomai Z., et al. No overall hyposialylation in hereditary inclusion body myopathy myoblasts carrying the homozygous M712T GNE mutation. Biochem Biophys Res Commun 328 (2005) 221-226
57. Satayoshi E., Sunohara N., and Nonaka I. Distal myopathy with rimmed vacuoles, inclusion-body myositis, and related disorders in Japan. In: Askanas V., Serratrice G., and Engel W.K. (Eds). Inclusion-Body Myositis and Myopathies (1998), Cambridge University Press, Cambridge 244-251
58. Schwarzkopf M., Knobeloch K.P., Rohde E., et al. Sialylation is essential for early development in mice. Proc Natl Acad Sci USA 99 (2002) 5267-5270
59. Seppala R., Lehto V.P., and Gahl W.A. Mutations in the human UDP-Nacetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme. Am J Hum Genet 64 (1999) 1563-1569
60. Sivakumar K., and Dalakas M.C. The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews. Neurology 47 (1996) 977-984
61. Stäsche R., Hinderlich S., Weise C., et al. A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Molecular cloning and functional expression of UDP-N-acetyl-glucosamine 2-epimerase/N-acetylmannosamine kinase. J Biol Chem 272 (1997) 24319-24324
62. Sunohara N., Nonaka I., Kamei N., et al. Distal myopathy with rimmed vacuoles formation: a follow-up study. Brain 112 (1989) 65-83
63. Tommitsu M., Ishikama K., Shimaso I., et al. Distal myopathy with rimmed vacuoles: Novel mutation in the GNE gene. Neurology 59 (2002) 454
64. Varki A. Sialic acids as ligands in recognition phenomena. FASEB J 11 (1997) 248-255
65. Vasconcelos O.M., Raju R., and Dalakas M.C. GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM. Neurology 59 (2002) 1776-1779
66. Watts G.D.J., Thorne M., Kovach M.J., et al. Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: exclusion of GNE and three other candidate genes. Neuromuscul Dis 13 (2003) 559-567
67. Watts G.D., Wymer J., Kovach M.J., et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36 (2004) 377-381
68. Wilhelmsen K.C., Blake D.M., Lynch T., et al. Chromosome12-linked autosomal dominant scapuloperoneal muscular dystrophy. Ann Neurol 39 (1996) 507-520
69. Yabe I., Higashi T., Kikuchi S., et al. GNE mutations causing distal myopathy with rimmed vacuoles with inflammation. Neurology 61 (2003) 384-386
70. Yoshida A., Kobayashi K., Manya H., et al. Muscular dystrophy and neuronal migration disorder caused by mutations in glycosyltransferase POMGnT1. Dev Cell 1 (2001) 717-724